Sp412
MANAGEMENT OF GASTROINTESTINAL COMPLICATIONS OF IMMUNOTHERAPY
Date
May 19, 2024
Tracks
Related Products
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
THE IMPACT OF PROTON-PUMP INHIBITOR USE ON THE INCIDENCE OF GASTROINTESTINAL TOXICITY TO CHECKPOINT INHIBITION
Background: Immune checkpoint inhibitors (ICIs) are used to treat several malignancies but predispose to systemic autoimmune inflammation referred to as immune-related adverse events (irAE). Upper and lower gastrointestinal (GI) tract inflammation are commonly encountered toxicities…
TYPE 3 AUTOIMMUNE PANCREATITIS: CLINICAL PROFILE AND RESPONSE TO STEROIDS
Diabetes mellitus (DM) and prediabetes are common complications of acute pancreatitis (AP) and have aroused general concern in recent years. The underlying mechanisms need to be addressed…